S100B and inflammatory bowel disease: Indeed, considering S100B as a possible IBD biomarker in biological fluids, its levels were found to be lower in patients than in healthy subjects both in serum [126] and in feces [127], while the levels of S100B in biological fluids were found to be higher in all the pathological conditions investigated as compared with healthy subjects.